Why is "Arketamine" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-30 19:30:55
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Arketamine (developmental code names PCN-101, HR-071603), also known as (R)-ketamine or (R)-(−)-ketamine, is the (R)-(−) enantiomer of ketamine. Similarly to racemic ketamine and esketamine, the S(+) enantiomer of ketamine, arketamine is biologically active; however, it is less potent as an NMDA receptor antagonist and anesthetic and thus has never been approved or marketed for clinical use as an enantiopure drug. Arketamine is currently in clinical development as a novel antidepressant.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Ketamine and Esketamine: Is There a Meaningful Clinical Difference? - Psychiatrist.com
-
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor - Nature
-
Is Ketamine a Miracle Drug for Mental Illnesses? - Psychiatry Advisor
-
A role of splenic heme biosynthesis pathway in the persistent prophylactic actions of arketamine in lipopolysaccharide-treated mice - Nature
-
10 emerging antidepressants to keep an eye on - drugdiscoverytrends.com
-
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression - Verywell Health
-
FDA expands Spravato approval, and the Future of RFK Jr. and federal agencies' approach to psychedelics in limbo - The Microdose | Substack
-
Ketamine: In-Clinic Administration - Psychiatry Advisor
-
Investors are starting to bet big on psychedelic medicine - CNBC
-
What's the Latest in Depression Treatment? - Verywell Mind
-
A new ketamine-based antidepressant raises hope — and questions - Science News
-
An Introduction to Five Psychedelics: Psilocybin, DMT, LSD, MDMA and Ketamine - Technology Networks
-
Good Trip - Asian Scientist Magazine
-
ATAI snags $125M to bankroll mental health pipeline - Fierce Biotech
-
FDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants with it - Boing Boing
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.